ACE inhibitors - angiotensin II receptor antagonists: A useful combination therapy for ischemic heart disease.

about

Protective Role of Ramipril and Candesartan against Myocardial Ischemic Reperfusion Injury: A Biochemical and Transmission Electron Microscopical Study.

P2860

Q39217232-31B4E7B4-19EF-4200-9D80-CAD1529050D9

P2860

ACE inhibitors - angiotensin II receptor antagonists: A useful combination therapy for ischemic heart disease.

Item

http://www.wikidata.org/entity/Q36726341

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

ACE inhibitors - angiotensin I ...... py for ischemic heart disease.

@ast

ACE inhibitors - angiotensin I ...... py for ischemic heart disease.

@en

type

Item

label

ACE inhibitors - angiotensin I ...... py for ischemic heart disease.

@ast

ACE inhibitors - angiotensin I ...... py for ischemic heart disease.

@en

prefLabel

ACE inhibitors - angiotensin I ...... py for ischemic heart disease.

@ast

ACE inhibitors - angiotensin I ...... py for ischemic heart disease.

@en

P1476

ACE inhibitors - angiotensin I ...... py for ischemic heart disease.

@en

P2093

K Bharani

http://www.w3.org/2001/XMLSchema#string

K Gauthaman

http://www.w3.org/2001/XMLSchema#string

T S Mohamed Saleem

http://www.w3.org/2001/XMLSchema#string

P2860

Role of bradykinin and eNOS in the anti-ischaemic effect of trandolapril

Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Angiotensin II receptor blockers: review of the binding characteristics.

Angiotensin II type 1 receptor blockers.

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.

Inflammatory cytokines and postmyocardial infarction remodeling.

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

Role of bradykinin in preconditioning and protection of the ischaemic myocardium.

P304

51-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/OAEM.S10507

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27147838

http://www.w3.org/2001/XMLSchema#string

P932

4806827

http://www.w3.org/2001/XMLSchema#string

ACE inhibitors - angiotensin II receptor antagonists: A useful combination therapy for ischemic heart disease.

about

P2860

P2860

ACE inhibitors - angiotensin II receptor antagonists: A useful combination therapy for ischemic heart disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932